You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
賽升藥業(300485.SZ):參股公司康樂衞士北交所IPO成功過會
格隆匯 12-25 16:24

格隆匯12月25日丨賽升藥業(300485.SZ)公佈,公司參股公司北京康樂衞士生物技術股份有限公司(簡稱“康樂衞士”)於2022年12月23日獲得北京證券交易所上市委員會審議通過。

北京證券交易所於2022年12月23日出具《北京證券交易所上市委員會2022年第85次審議會議結果公吿》:北京康樂衞士生物技術股份有限公司符合發行條件、上市條件和信息披露要求。

康樂衞士為公司參股公司,截止目前,公司持有康科衞士68.2萬股,佔該公司發行前總股本的比例為0.51%。公司之關聯方北京亦莊生物醫藥併購投資中心(有限合夥)持有康樂衞士300萬股,佔該公司發行前總股本的比例為2.25%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account